A Randomized, Double-Blind, Parallel Group Study To Compare Discontinuation Symptoms In Abrupt Discontinuation Versus A 1-Week Tapering Regimen In Subjects With MDD Treated For 24 Weeks With Open-Label 50 mg DVS SR Formulation
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006819/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Study Comparing Discontinuation Symptoms in subjects with Major Depressive Disorder treated
for 24 Weeks with Open-label 50 mg Desvenlafaxine Succinate Sustained-Release Formulation
(DVS SR)
提供机构：
Vivli
创建时间：
2021-04-02
